Apr 09, 2024

Starpharma and Medicxi to partner in Petalion Therapeutics, advancing dendrimer-drug cancer treatments

"Australian biotech Starpharma Holdings (ASX: SPL) has entered into a strategic partnership with UK life sciences investment firm Medicxi to establish a UK-based company known as Petalion Therapeutics." 

Visit Small Caps to read the full article.

 This contains certain forward-looking statements.